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TUBERCULOSIS thought to be one of the oldest human diseases, the history of TB is 
atleast as old as the mankind over the years, not only the medical implications but also 
the social and economic impact of TB has been TUBERCULOSIS has been a major 
cause of suffering and death since times immemorial. (1) 
 At the dawn of the new millennium, we are still mute witnessess  to the silent yet 
efficient march of this sagacious disease, its myriad manifestationsand above all its 
unequalled ,vicious killing power through the millennia.TB never ever disappeared from 
the developing world.(1) 
Most technologically advanced world has seen more than a century of declining 
incidence of tuberculosis but the less developed world has not been so fortunate and in 
those populous regions TB incidence is increasing. In acquired immunodeficiency region 
(AIDS) stricken regions – sub Saharan Africa, For example –TB case rates now are 50-
100 times those in North America and Europe. Spurred by immune deficiencies resulting 
from HIV infection, these case rates will continue to increase in coming decades. 
The history of Tuberculosis reveals that this disease has swept across large regions of the 
world in slowly moving epidemic waves with periods measured in centuries. The factors 
contributing to the rise and decline of these waves are only partially known and are 
difficult to control in the absence of massive and political changes. There is however, 
much that we might learn from considering the historical spread of TB and the ways in 
those countries now favoured with low TB incidences managed their high incidence 
problems in their region. 
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In pulmonary tuberculosis patients are dependent on sputum smear/culture based 
monitoring of treatment, but this will be challenging to use in extra pulmonary TB, and in 
patients with pauci -bacillary disease such as is seen in HIV-coinfected patients and in 
children. Both sputum volume and quality decreases in response to treatment and many 
patients cannot provide sputum samples for culture/smear after a few weeks of treatment. 
The development of non-sputum-based biomarkers of treatment response would represent 
an advance for individual monitoring of TB patients. 
Hence we proposed that these inflammatory markers will be an indespensible tool in 
assessement of tuberculosis disease severity and their fall in response to treatment will be 
a surrogate marker of disease control. We selected the inflammatory marker CRP-c-
reactive protein, ESR-erythrocyte sedimentation rate, NLR- neutrophil lymphocyte ratio, 
RDW-red cell distribution width in our study and proceeded. 
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BURDEN OF TUBERCULOSIS 
 
 
 
The regions shown in red are very high burden countries, that is the incidence rate is 
>300//1,00,000, they are mostly African countries. India belongs belong to high burden 
country having incidence rate of> 200-300 per 1 lac people. 
India accounts for one fourth of global tuberculosis incidence, 2.2 million out of 9.6 
million cases annually. In India more than 40% are infected with tuberculosiswith 
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mycobacterium tuberculosis (prevalence of infection). It is estimated that there are 2.5 
million prevalent cases of all form of tuberculosis. it is also estimated 2.2 lakhs people 
die of TB annually. 
 Incidence  Prevalence  mortality 
Global 9.6 million 
176/lac year 
13 million 
227/lac /year 
1.1 million 
21/lac /year 
India 2.2 million 
167/lac/year 
2.5 million 
197/ lac/year 
2.2 lakhs 
17/ lac/year 
 
 Tuberculosis (TB) is one of the top 10 causes of death worldwide. 
 In 2017, 10 million people fell ill with TB, and 1.6 million died from the disease 
(including 0.3 million among people with HIV). 
 Millions of people fall sick with TB each year,there were cases and age groups but 
overall 90% were adults,9% were those living with HIV and 2/3rd were in eight 
countries ; INDIA (27%),china (9%),Indonesia (8%), the Philippines, Pakistan, 
Nigeria, Bangladesh, and South Africa amounting to 4-7 %  
 In 2017, an estimated 1 million children became ill with TB and 230 000 children 
died of TB (including children with HIV associated TB). 
 TB is a leading killer of HIV-positive people. 
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 TB is a leading killer of HIV-positive people: in 2016, 40% of HIV deaths were 
due to TB. 
 Multidrug-resistant TB (MDR-TB) remains a public health crisis and a health 
security threat. WHO estimates that there were 5,58 000 new cases with resistance 
to rifampicin – the most effective first-line drug, of which - 82% had MDR-TB. 
 Globally, TB incidence is falling at about 2% per year. This needs to accelerate to 
a 4–5% annual decline to reach the 2020 milestones of the End TB Strategy 
 An estimated 54 million lives were saved through TB diagnosis and treatment 
between 2000 and 2017. 
 Ending the TB epidemic by 2030 is among the health targets of the Sustainable 
Development Goals (12) 
Impact Indicators for the National Strategic Plan 2017 – 2025 
 
2015 2020 
To reduce estimated TB incidence (rate per 100,000) 217 142 
To reduce estimated TB prevalence (rate per 100,000) 320 170 
To reduce estimated mortality due to TB (per 100,000) 32 15 
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TUBERCULOSIS IMMUNO PATHOGENESIS 
TB is a communicable infectious disease, spread almost exclusively by coughed 
aerosols carrying pathogens from the mycobacterium tuberculosis complex. TB is 
characterized pathologically by necrotizing granulomatous inflammation usually in the 
lung, although any extra pulmonary site can be involved. 
Protective immunity and varied clinical manifestations of infection with mycobacterium 
tuberculosis represent a delicate balance between the bacillus and the type as well as 
magnitude of immune response elicited by the host.(1)The immune system is extremely 
complex and some of the intricacies of its function are not completely 
understood.Essentially tuberculosis is a struggle between the macrophage and bacilli(2) 
The epidemiology of TB in a community is the resultantof the interplay between the 
environmental conditions,socioeconomic state of the population, the host factorsand the 
agent characteristics. The course of the eventsfollowing infection as observed in 
humanbeings, followed by that in the community at large.(1) 
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The above figure shows the natural history of tuberculosis. 
 
 
 
    EVENTS DURING TB INFECTION 
 
. Broadly, TB infection is divided into four phases: First phase includes an initial 
establishment of Mycobacterium tuberculosis infection in the resident macrophages 
[alveolar]. This is followed by influx of PMNs, which prevents Mycobacterium 
tuberculosis to escape from the innate immune factors. Subsequently, monocytes are 
recruited to the site of infection/ pathological site [second phase]. Third phase includes 
granuloma formation. Core of granuloma is made up of multinucleated giant cells and 
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elongated epithelioid cells. These are surrounded by T-cells. This is aimed at restricting 
the bacilli from spreading. The fourth and terminal phase includes dissemination of 
bacilli. Defective granuloma formation promotes release of bacilli from control of 
immune system. Organs/loci targeted by bacilli after dissemination are listed  
 
The cytokine network and its interactions are complex in the setting of infection by 
mycobacterium tuberculosis. Conventional understanding supports a pivotal role for 
cytokines in the overall immune responses to TB. Although cytokines are produced by 
the wide variety of cells, primed lymphocytes are the major producers. Particularly two 
sub populations of CD4+ T lymphocytes - the T helper type 1 (TH)  cells that produce 
IL-2 , IFN –gamma, lympho-toxin alpha,and other proinflammatory cytokines,and the T 
helper type 2  (TH-2 ), cells that produce IL-4,IL-5,IL-10,IL-13,and other anti-
inflammatory cytokines.(3) 
In the immune response,the cytokines produced participate in the regulatory processes as 
well as in effector functions and are involved in the activation and proliferation of 
macrophages and T lymphocytes. Thus specific antigens to mycobacteria interact with 
toll like receptors (TLRs) and other receptors present on surface of macrophages and 
dendritic cells, thus inducing a cellular immune response predominantly pro-
inflammatory.(4) 
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After infection, innate immune responses try to put check on increasing infection. 
Meanwhile immature DC s after taking up antigen, move towards the draining lymph 
nodes and antigen recognition and presentation to t cells occur inside the 
regional/draining lymphnodes.  Recruitment of antigen specific T cells at the pathological 
sites and production of pro-inflammatory cytokines lead to granuloma formation. Later 
on depending on the presence of TH1/TH2 skewed response, dissemination or 
containment of bacilli occurs. 
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IMMUNE RESPONSE IN TUBERCULOSIS 
PATHOGENESIS 
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Orchestration of effector immune component in building up response against 
Mycobacterium tuberculosis. Priming of T-cellsfor effector functions requires 
recognition by activated macrophages with stimulation by a battery of potentiating 
cytokines [IL-12, IL-6, IL-1β etc.,] released by the infected macrophages. The response 
of effector T-cells will decide the extreme/polarity of upcoming disease pathogenesis. 
Regulatory T-cells [CD4+CD25+FoxP3+ T-cells, natural killer T-cells etc.,] can also 
modulate the protective effector T cell responses either in a contact 
dependent/independent way. 
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The inflammatory reaction is accompanied by a systemic response known as acute phase 
response (APR).This response is characterized by fever, production of different types of 
hormones, leukocytosis and protein synthesis in series, which is rapidly regulated mainly 
in hepatocytes under the control of cytokines arising from the site of the pathology. Thus 
this acute phase response bring about alteration in hematological indices like 
leukocytosis, neutrophilia, lymphopenia, thrombocytosis, red cell distribution width, 
platelet distribution width, haematocrit, plateletocrit, erythrocyte sedimentation rate, etc. 
and acute protein like c-reactive protein ,serum amyloid A etc. These serum markers of 
inflammation rise above the range of normal during active infection at par with the 
severity of infection and will fall when the infection severity comes down. 
In pulmonary tuberculosis patients are dependent on sputum smear /culture based 
monitoring of treatment,but this will be challenging to use in extra pulmonary TB, and in 
patients with pauci -bacillary disease such as is seen in HIV-coinfected patients and in 
children. Both sputum volume and quality decreases in response to treatment and many 
patients cannot provide sputum samples for culture/smear after a few weeks of treatment. 
The development of non-sputum-based biomarkers of treatment response would represent 
an advance for individual monitoring of TB patients. 
Hence we proposed that these inflammatory markers will be an indespensible tool in 
assessement of tuberculosis disease severity and their fall in response to treatment will be 
a surrogate markers of disease control. We selected the inflammatory marker CRP-C-
reactive protein, ESR-erythrocyte sedimentation rate, NLR- neutrophil lymphocyte ratio, 
RDW-red cell distribution width in our study and proceeded. 
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In a study done by Abakay o et al inflammation on 2015…..they aimed to 
investigate the correlation between red cell distribution width (RDW), neutrophil to 
lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and other inflammatory 
markers with PTB severity. 70 patients with active PTB were compared with 50 age and 
gender matched healthy control people without any illness. The mean age of PTB patients 
in their study were 50.4 ± 21.8 years. There were no significant differences in terms of 
age, gender, and smoking history between PTB patients and controls. Patients with 
advanced PTB had a significantly higher white blood cell count, neutrophil count, Red 
cell distribution width, Neutrophil lymphocyte ratio, and CRP. When compared to 
patients with mild to moderate PTB. RDW (17.7 versus 15.7 %, p=0.002) and NLR (4.7 
versus 3.1, p=0.009) values were higher in patients with advanced PTB as opposed to 
patients with mild to moderate PTB. NLR and RDW levels may be used as markers of 
inflammation to help clinically manage patients with TB and to determine disease 
severity(9) 
In a study done by Furuhashi k,et al.kakkaku.2012…they studied that Few inflammatory 
markers closely reflect the activity of tuberculosis and only a few surrogate markers are 
available. They wanted to clarify the usefulness of measuring the erythrocyte 
sedimentation rate (ESR), C-reactive protein (CRP), and serum amyloid A (SAA), and 
the association between these markers and T-cell profiles. They enrolled One hundred 
one patients with active pulmonary tuberculosis. The associations between ESR, CRP, 
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and SAA values on admission and radiological and microbiological findings and T-cell 
profiles were assessed. Th1/Th2 and Tc1/Tc2 were determined by analyzing intracellular 
cytokine staining for IFN-gamma and IL-4 in blood CD4+ and CD8+ T cells using flow 
cytometry after stimulation with PMA and ionomycin. There found a significant 
correlations between ESR, CRP, and SAA of which the correlation between CRP and 
Serum amyloid A was strong (r = 0.88). CRP values significantly correlated with the 
sputum smear scale and the extent of lesions, and were higher in bilateral lesions. SAA 
values correlated with the sputum smear scale, whereas all markers were higher in 
patients with pleural effusion. Both CRP and SAA levels negatively correlated with the 
ratio of Th1/Th2. In contrast, ESR negatively correlated with the ratio of Tc1/Tc2.C 
reactive protein reflected the disease severity before treatment. CRP and SAA values 
were associated with helper T-cell proportions whereas ESR was associated with 
cytotoxic T-cell proportions, both being type 2 predominant. (10) 
 
In a study done by mohd yousoof dar et al ….. they evaluated the immulogical 
markers namely serum C reactive protein and interferon gamma levels in cases of active 
pulmonary tuberculosis and the effect of anti -tubercular treatment on the level of these 
markers.They did a cross sectional study was on total of 54 patients of sputum positive 
pulmonary tuberculosis and also 10 healthy controls. C reactive protein and INF-¥ was 
performed on sputum samples and blood by ELISA method. The Mean Serum CRP level 
in Controls were 2.15±1.3 mg/dl. In cases it was found to be 21.71±6.73 mg/dl at 
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baseline. The markers Levels decreased further at 2 months to 7.70±4.29 mg/dl and 
2.41±1.5 mg/dl at end of 6 months (p < 0.001) 
The mean Serum Interferon -¥ levels in cases at baseline were 41.47±43.25 pg/ml 
compared to the controls 1.81±1.6 pg/ml (p < 0.003). After treatment at 2 months the 
serum IFN-¥ levels after was 12.53±8.33 pg/ml and at end of 6 months it was 2.47±1.55 
pg/ml (p < 0.001). Serum Interferon-¥ levels was comparable to controls at the end of 6 
months. Mean sputum IFN-¥ levels at baseline was 24.92±16.53 pg/ml. It decreased after 
2 months of treatment to 7.68±5.17 pg/ml and at end of 6 months to 3.86±3.12 pg/ml (p < 
0.001).thus they concluded that the Patients with pulmonary TB have significantly 
elevated serum CRP and IFN-¥ levels compared to normal controls and levels of these 
makers decrease significantly with treatment. Hence they concluded serum CRP and IFN-
¥ (both serum and sputum) may be useful in early detection of disease and in monitoring 
the response.(13) 
In a study done by hamida et al…..The study group has 44 men. The mean age 
was 41 years in the two groups. Tobacco smoking was more common in the group of 
patients with elevated CRP. In both groups, clinical features were dominated by 
decreased general status and cough. Cavitary lung lesions were more frequent in patients 
with elevated CRP (16 cases vs 3 cases) often with an extensive and bilateral pulmonary 
involvement (15 cases vs 3 cases).Similarly,  acid-fast bacilli positivity found in sputum 
were more frequent in the group of patients with elevated CRP (22 cases vs 6 cases).After 
excluding patients lost during the treatment, well clinical, bacteriological and radiological 
24 
 
evolutions were noted in the term of six months in the majority of patients with CRP <50 
mg / l (11 cases vs 10 cases). In 4 patients with elevated CRP, there was a delay (more 
than1month) to bacilli become negative. Thus CRP can be used as marker of disease 
activity and to assess treatment response.(15) 
In a study done at Ethiopia..bamalkku et al…..Their aim of the study was to determine 
hematological profiles of TB patients before and after intensive phase treatment. The hematological 
profiles of TB patients studied. They showed statistically significant difference in 
hematocrit (38.5 % versus 35.7 %), hemoglobin (12.7 g/lversus11.8 g/l) and platelet 
(268 × 103/μlversus239 × 103/μl) values of patients before initiation of treatment and after 
completion of the intensive phase of tuberculosis treatment, respectively. The red cell 
distribution width (RDW) of treatment naïve TB patients was by far lower 
(17)(17.6 ± 7.09 %) than the corresponding RDW (31.9 ± 5.19 %) of intensive phase 
treatment completed patients. Among TB patients that had high platelet distribution width 
(PDW) (n = 11) before initiation of TB treatment, 10 demonstrated lower PDW values 
after completion of the intensive phase. There was no significant difference on total white 
blood cell count among TB patients before and after completion of the 2 month 
treatment.They concluded that the hematological abnormalities in TB patients to be 
monitored throughout the treatment. The levels of hemoglobin, hematocrit and platelet 
count of the TB patients were significantly lowered after completion of the intensive 
phase of TB treatment. Significant variation of the RDW and PDW were also observed 
among treatment naïve and after completion of treatment. Hematological abnormalities 
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resulted from TB treatment should be assessed continuously throughout the course of 
tuberculosis therapy.16) 
 
In a study done by marina oliveria et al…..in patients with active pulmonary tuberculosis 
they found low hemoglobin levels (mean, 10.86 ± 2.04 g/dL) in 89.2% of patients; low 
transferrin levels (mean, 177.28 ± 58.71 mg/dL) in 65.3%; and low MCV (mean, 82.00 ± 
7.77 fL) in 39.7%. In addition, we found high ferritin levels (mean, 520.68 ± 284.26 
ng/mL) in 52.7% of patients; high RDW (mean, 16.36 ± 3.47%) in 55.4%; high CRP 
levels (mean, 5.84 ± 4.22 mg/dL) in 98.2%; and high ESR (mean, 60.30 ± 39.84 mm/h) 
in 84.3%. they concluded that the prevalence of anemia gives rise to increased RDW.(17) 
In a study done by yin y et al at china….they studied pretreatment neutrophil 
lymphocyte ratio in pulmonary tuberculosis. According to the ROC curve, the best cut-
off value of NLR was 2.53, with a sensitivity of 70.6% and a specificity of 45.4%. The 
NLR ≥ 2.53 before anti-TB treatment was associated with PTB retreatment (OR = 1.994, 
95% CI: 1.116-3.564; adjusted OR (AOR) = 2.409, 95% CI: 1.212-4.788). The 
retreatment rates with NLR ≥ 2.53 and NLR < 2.53 were 27.1% and 15.5%, respectively, 
with a significant difference (log-rank test; p = 0.010). Additionally, cavitation on chest 
X-ray (OR = 2.922, 95% CI: 1.654-5.411; AOR = 2.482, 95% CI: 1.230-5.007), history 
of smoking (OR = 2.202, 95% CI: 1.158-3.493; AOR = 2.321, 95% CI: 1.135-4.745) and 
age ≥ 60 (OR = 3.828, 95% CI: 1.626-9.015; AOR = 2.931, 95% CI: 1.122-7.653) were 
also associated with PTB retreatment. NLR ≥ 2.53 is predictive of PTB retreatment.(18) 
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 In a study done by pyrosila Miranda they studied 134 pulmonary TB patients 
…they measured ferritin and CRP levels …they found Circulating levels of both ferritin 
and CRP gradually decreased over time on ATT. At pre-treatment, concentrations of 
these parameters were unable to distinguish patients with positive from those with 
negative acid-fast bacilli (AFB) in sputum cultures. However, patients who remained 
with positive cultures at day 60 of ATT exhibited heightened levels of these 
inflammatory markers compared to those with negative cultures at that time point.CRP 
and Ferritin levels in serum may be useful to identify patients with positive cultures at 
day 60 of ATT (19) 
IN a study done by leem ay et al….. …they studied the changes in multiple cytokines and 
inflammatory markers in active TB patients following anti-TB drug therapy. Twenty-nine 
patients with active TB were recruited prospectively between December 2010 and July 
2017. Blood samples were collected before (T0), after 2 months (T2), and at the end of 
anti-TB treatment (Tend). We measured the levels of Interferon (IFN)-γ, interleukin (IL)-
2, IL-12, IL-10, IL-13 and tumor necrosis factor (TNF)-α in supernatants collected from 
the QuantiFERON-TB Gold In-Tube assay (QFT-GIT), as well as the WBC, neutrophil, 
platelet count and neutrophil to lymphocyte ratio (NLR) in whole blood. Compared with 
baseline levels, WBC, neutrophil, and platelet counts were significantly lower following 
treatment. In addition, the NLR after treatment significantly decreased compared with 
baseline, whereas the IL-2/IFN-γ ratio increased after treatment. In conclusion, the levels 
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of IL-2/IFN-γ ratios in the supernatant and the NLR might be useful biomarkers to 
evaluate the effectiveness of drug therapy in active TB patients.(20) 
A study was done to explore the claim that anisocytosis as measured by the red 
blood cell volume distribution width (RDW) is raised in iron-deficiency anemia, but is 
normal in the anemia of chronic disorders. In a study done by banes et al Measurements 
were done  for 283 normal patients, 22 iron-deficient patients, and 102 tuberculosis 
patients, using a model S plus Coulter Electronic Counter with standard calibration. Mean 
(+/- standard deviation values for RDW were as follows: normal patients, 7.36 (+/- 0.57); 
untreated patients iron deficiency, 10.39 (+/- 1.37); and 15 not treated anemic patients 
with tuberculosis, 10.44 (+/- 0.63). Mean values remained above 10.4 in 69 patients with 
tuberculosis during treatment, irrespective of whether or not the patients are anemic, but 
value ad fallen towards the normal mean (8.49 +/- 0.8) in the 18 subjects in whom it was 
measured at the end of therapy. By this time the mean corpuscular volume (MCV) and 
hemoglobin concentrations had risen to normal. It is concluded that Red cell distribution 
width values in the chronic inflammatory disorder tuberculosis are not significantly 
different from those occurring in iron-deficiency anemia.(21) 
In a Russian study .they studied Two hundred and forty-three patients with 
different forms of active pulmonary tuberculosis patients. The level of C-reactive protein 
(CRP) was determined by immune turbidimetry. C reactive protein normal values were 
taken to be 0-3 mg/l. The increased CRP levels revealed in 80.7% of the patients formed 
two peaks in the ranges of 4-5 (25.1%) and 21-100 (28.9%) mg/l. The higher values of 
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CRP with the maximum of 239 mg/l were found in 11.1% of patients. The values of CRP 
clearly correlated with the degree of intoxication, the presence and rate of bacterial 
discharge, the extent of the process, the absence or presence of decay. By the end of an 
intensive phase of chemotherapy (3 months) in case of its efficiency, the level of C 
reactive protein significantly decreased thus approaching to the upper clinical range (12.1 
+/- 1.9 mg/l) whereas in ineffective treatment it was substantially unchanged (22) 
In a study done by RAO et al they found that C-reactive protein levels were  
significantly higher in smear-positive group as compared with the smear-negative group, 
the values being 37.598 ± 23.195 and 5.40 ± 1.88 respectively (P < 0.0005). Among the 
smear-positive patients, CRP levels were highest in Smear3+ group (60.00 ± 15.69) as 
compared with the Smear2+ patients (35.83 ± 8.9) and Smear1+ (5 ± 7.86). Statistically, 
the difference was found to be significant (P< 0.0005). Correlation of CRP levels with 
extent of disease also revealed that these values were significantly higher in stage III 
disease (52.44 ± 17.78) as compared with stage II (13.19 ± 13.03) and stage I disease (9.5 
± 9.01).  Serum CRP levels may have a role in identifying the advanced and extensive 
disease patients thereby indirectly helping the health workers to pick up delayed 
convertors/potential defaulters, so as to guide them to put in extra efforts on these groups, 
in tuberculosis control programs.(23)  In a study done by RAO et al they found thatC-
reactive protein levels were  significantly higher in smear-positive group as compared 
with the smear-negative group, the values being 37.598 ± 23.195 and 5.40 ± 1.88 
respectively (P < 0.0005). Among the smear-positive patients, CRP levels were highest in 
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Smear3+ group (60.00 ± 15.69) as compared with the Smear2+ patients (35.83 ± 8.9) and 
Smear1+ (5 ± 7.86). Statistically, the difference was found to be significant (P< 0.0005). 
Correlation of CRP levels with extent of disease also revealed that these values were 
significantly higher in stage III disease (52.44 ± 17.78) as compared with stage II (13.19 
± 13.03) and stage I disease (9.5 ± 9.01). Serum CRP levels may have a role in 
identifying the advanced and extensive disease patients thereby indirectly helping the 
health workers to pick up delayed convertors/potential defaulters, so as to guide them to 
put in extra efforts on these groups, in tuberculosis control programs.(23) 
This study done by chio et l at Department of Internal Medicine, Armed Forces 
Capital Hospital, Seoul, Republic of Korea. The physicians are frequently faced with the 
difficult task of differentiating between pulmonary tuberculosis (PTB) and pneumonia. 
They evaluated the role of the C-reactive protein test (CRP) for differentiating between 
TB and pneumonia among military personnel in South Korea. Only immune competent 
males were eligible. Forty-six patients with Pulmonary tuberculosis and 67 with 
pneumonia were enrolled prospectively. Median C reactive protein concentration was 
somewhat lower in patients with TB than in patients with non-tuberculous pneumonia 
(3.2 mg/dl [range 0.1-15.7 mg/dl] vs. 8.3 mg/dl [range 0.2-33.7 mg/dl], P < 0.001). The 
sensitivity and specificity for TB of a low CRP concentration (< 11.2 mg/dl) in serum 
was 93.3% and 40.9%, respectively. CRP concentration measurement might be useful for 
eliminating the diagnosis of TB.(24) 
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In a study done by mohammed kalih sekh et al: The present study was conducted 
to evaluate the C-reactive protein (CRP) in patients with pulmonary tuberculosis at 
Liaquat University Hospital, Hyderabad, Pakistan. All patients with pulmonary 
tuberculosis > 12 years of age, of either gender were evaluated for their serum CRP level. 
During twelve months study period, 127 patients with pulmonary tuberculosis were 
evaluated for CRP level, of which 76 (60%) were males and 51 (40%) were females. The 
observed symptoms were cough and expectoration 115 (91%), weakness and constant 
fatigue 92(72%), weight loss 110 (86%), fever 90(71%), night sweats 85(67%), chest 
pain 95(75%), coughing up blood 98(77%), loss of appetite 88(69%), headache 102(80%) 
and combined / mixed symptoms 100(79%). The overall mean CRP in patients with TB 
was 9.87±4.83 where as it was 11.21±3.32 and 13.82±4.63 in male and female subjects 
respectively. The mean±SD of normal and raised serum CRP was 2.76±1.34 and 
13.26±4.42 (p 0.01). The complications observed in patients with raised serum CRP were 
pneumothorax 04(4.7%), fibrosis 08(9.3%), miliary TB 06(7%), empyema 10(11.6%), 
fungal colonization within tuberculous cavity 09(10.5%), bronchiectasis 11(12.8%), more 
than 01 complication 11(12.8%) and Nil 19(22.1%). The present study detected elevation 
of CRP in pulmonary tuberculosis and a high CRP is clearly associated with more severe 
disease.(25) 
In a study done at brazileliene et al Circulating levels of cytokines (IL-2, IL-4, IL-6, IL-
10, IFN-γ, TNF-α) and C-reactive protein (CRP), as well as values of erythrocyte 
sedimentation rate (ESR) were measured in cryo preserved serum samples obtained from 
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73 PTB patients at pre-ATT and day 60 of treatment. Changes of the immune profile over 
time were compared with mycobacterial loads in sputum and culture conversion at day 60 
of ATT. Additional analyses tested associations between improvement of chest 
radiographic lesions at day 60 and pre-treatment status of inflammation and 
mycobacterial loads.Within the inflammatory parameters evaluated, values of c reactive 
protein, interlukin-2, Iinterlukin-4, Tumour necrosis factor-α and Erythrocyte 
sedimentation rate significantly decreased upon treatment initiation. On the converse, IL-
10 levels substantially increased at day 60 of ATT, whereas concentrations of IL-6 and 
IFN-γ remained unchanged. Multidimensional analyses revealed that ESR, IL-2, IL-4 and 
C reactive protein were the parameters with the highest power to discriminate individuals 
before and after treatment initiation, they demonstrated that higher bacterial loads in 
sputum at pre-Anti tuberculous treatment were associated with increased systemic 
inflammation and higher risk for positive M. tuberculosis sputum cultures at day 60 of 
treatment. Furthermore, we found that pre-ATT mycobacterial loads in sputum and 
systemic inflammation synergistically associated with the status of radiographic lesions 
during treatment (Relative risk for chest X-ray improvement: 10.0, 95 % confidence 
interval: 2.4–40.0, P = 0.002). The mycobacterial loads in sputum are directly associated 
to the status of systemic inflammation and potentially impact the immune profile, the 
culture conversion and the evolution of lung lesions upon Anti tuberculous treatment 
initiation (26) 
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In a study done by yoon et al …THEY identified nine unique studies enrolling 
1793 adults from out-patient (five studies, 1121 patients) and in-patient settings (five 
studies, 672 patients), 72% of whom had confirmed HIV infection. Among out-patients, 
CRP had high sensitivity (93%, 95%CI 88-98) and moderate specificity (60%, 95%CI 
40-75) for active PTB. Specificity was lowest among in-patients (21%, 95%CI 6-52) and 
highest among out-patients undergoing TB screening (range 58-81%). There was no 
difference in summary estimates by HIV status CRP, which is available as a simple, 
inexpensive and point-of-care test, can be used to screen PLHIV presenting for routine 
HIV/AIDS (acquired immune-deficiency syndrome) care for active TB.(27). 
In a study at bt yaji han et alA total of 96 patients were enrolled. Seventeen 
patients (18%) died during hospitalization due to miliary TB, and 9 (9%) died 
additionally during the 1-year follow-up period. Eighteen patients (19%) were diagnosed 
with acute respiratory distress syndrome (ARDS). In multiple logistic regression 
analyses, increased NLR was associated with ARDS [adjusted odds ratio, 1.15; 95% 
confidence interval (CI), 1.03–1.28]. By multivariate Cox regression analysis with 
adjustment of known prognostic factors including age, sex, body mass index, serum 
aspartate aminotransferase (AST), and hemoglobin, NLR was an independent predictor of 
in-hospital mortality [adjusted hazard ratio (aHR), 1.08; 95% CI, 1.03–1.13] and 1-year 
mortality (aHR, 1.08; 95% CI, 1.05–1.12) Pre-treatment NLR at admission may be a 
useful biomarker for mortality and development of ARDS in patients with miliary TB. 
(28) 
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In a study done by mahalakshmamma et al at telengana…..they studied 
erythrocyte Sedimentation Rate (ESR) as a marker for inflammation in the body. It is the 
initial test carried out in order to detect infection using Westergrens tube in which ante 
cubital venous blood is mixed with sodium citrate as an anticoagulant. This study was 
performed in, pulmonary tuberculosis patients who were taking treatment in hospital and 
normal young healthy individuals were randomly selected as controls. They were divided 
into 3 Groups, Group-1 normal and pulmonary tuberculosis patients, Group-2 before 
treatment and after treatment, Group-3 contains BMI for Both Groups, mean SD and p 
values are statistically studied by using ANOVA. ESR may help to find out the prognosis 
of the disease. Determination of Erythrocyte sedimentation rate after the treatment with 
anti tubercular drugs helps in determine the effectiveness of the drugs used and there by 
estimate the prognosis of the disease From the above observations it can be concluded 
that the ESR significantly increases in pulmonary tuberculosis and with adequate 
treatment with anti tubercular agents (drugs), the ESR significantly decrease also. 
Tuberculosis is a destructive disease as well as a chronic disease and therefore, fibrinogen 
and gamma globulin levels increase .which will increase the rouleaux formation and 
thereby ESR. Greater the level higher is the ESR and which may help to find out the 
gravity of the disease process. Determination of ESR after the treatment with anti-
tubercular drugs help determine the effectiveness of the drugs used and thereby the 
prognosis if it is good or bad. Anti tubercular drugs (streptomycin, INH, rifampicin) that 
have been used are the drugs that effectively decrease  
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In a study done by Charles et al….They studied the extent and severity of hematological 
and biochemical abnormalities which occurred in 265 patients with pulmonary 
tuberculosis, and records the hematological changes that occur with treatment. Anaemia 
was present in 60 per cent of patients, which more frequently in males than in females. 
Leucocytosis with neutrophilia occurred in 40 per cent, lymphopenia in 17 per cent and 
monocytopenia in 50 per cent. Platelet count and erythrocyte sedimentation rate were 
elevated in 52 and 80 per cent respectively. Bone marrow aspiration and trephine biopsy 
were of limited diagnostic value. Ferritin and vitamin B12 levels were increased in 94 and 
57 per cent of subjects respectively whilst serum and red cell folic acid were within 
normal limits in 83 per cent. The frequency of the important biochemical changes were 
hyponatremia (43 per cent) and hypoalbuminemia (72 per cent); alkaline phosphatase, 
aspartic transaminase and lactic dehydrogenase levels were elevated in approximately a 
third of patients possibly due to unsuspected dissemination. 
There was a close correlation between the acid-fast bacilli in sputum and abnormal 
values, particularly those of body weight, hemoglobin, platelet count, white cell count 
and erythrocyte sedimentation rate. Failure of these indices to return to normal was 
invariably associated with persistent excretion of acid-fast bacilli. They have shown that 
hematological and biochemical abnormalities in pulmonary tuberculosis are common and 
may be valuable aids to diagnosis. Some hematological markers also reflect response to 
treatment.(32) 
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In a study done by singh kj et al…they felt that Hematological changes associated 
with tuberculosis have been incompletely investigated, so In the present study, they have 
compared peripheral blood and bone marrow findings in patients with 
disseminated/miliary tuberculosis (DTB/MTB) as well as pulmonary tuberculosis (PTB). 
They have also attempted to assess the effect of anti-tuberculosis therapy on the 
hematologic abnormalities. Thirty two patients with disseminated/miliary tuberculosis 
and 23 patients with pulmonary tuberculosis had been prospectively studied to determine 
the various hematological manifestations in tuberculosis and the effect of anti- 
tuberculosis therapy. All patients received standard antituberculosis treatment. They were 
subjected to a detailed hemogram including peripheral blood examination, which was 
repeated on completion of anti -tuberculous therapy. Bone marrow aspiration and biopsy 
was also done in all patients before starting ATT 
Normocytic normochromic anemia was the most common abnormality observed 
in all the groups and subgroups (DTB/MTB 84%, PTB 86%). Other hematological 
abnormalities of the white blood cells include leucopenia (DTB/MTB 25%, PTB 0%; p < 
0.02), neutropenia (DTB/MTB 22%, PTB 0%; p < 0.04), lymphocytopenia, 
monocytopenia, leukocytosis, neutrophilia, lymphocytosis and monocytosis. 
Pancytopenia was observed only in patients with disseminated/miliary tuberculosis (p < 
0.05). Thrombocytopenia was more common in patients with disseminated/miliary 
tuberculosis (p < 0.007), whereas thrombocytosis was more common in patients with 
pulmonary tuberculosis (p < 0.04). The patients of disseminated/miliary tuberculosis with 
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granulomas in the bone marrow had certain significant differences as compared to 
patients without granulomas. These patients showed severe anemia, peripheral 
monocytopenia and bone marrow histiomonocytosis. The hemogram reverted to normal 
with antituberculosis therapy in these patients. 
In view of the varied hematological abnormalities observed in patients with 
tuberculosis in this part of the world, they concluded that the differential diagnosis of 
tuberculosis should be entertained in patients with varied hematological disorders. (33) 
In a study done at Babylon…. They aimed to study the changes of some 
hematological parameters in patients affected with pulmonary tuberculosis in Babylon 
province. 90 patients with PTB (45 males and 45 females) and 40 healthy controls (20 
males and 20 females) have included in present study. Patients have been classified into 
three groups: thus group1 includes newly diagnosed patients, group 2 includes patients 
after two months from starting treatment and group 3 includes patients after six months 
from starting treatment. The mean of ages was 44 ± 2 years for patients and 42 ± 2 years 
for the control. This study found that values of Hb, PCV, platelets and ESR for both 
sexes were significantly changed in group 1 in comparison with group 2. Values of 
Hemoglobin, Packed cell volume, platelets and ESR for both sexes were significantly 
changed in group 1 in comparison with group 3. This study had showed that values of 
Hb, PCV, platelets and ESR values for both the sexes were significantly changed in 
group 1 in comparison with healthy controls. Values ofthe platelets and ESR for both 
sexes and values of PCV for the males were insignificantly changed while the values of 
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Hemoglobin for both sexes and values of PCV for females were significantly changed in 
group 2 in comparison with group 3. This study showed that values of PCV for males 
were insignificantly changed while values of Hemoglobin, platelets and Erythrocyte 
sedimentation rate for both the sexes and PCV for females were significantly changed in 
group 2 in comparison with healthy controls. The results has proved that the values of 
platelets and ESR for both sexes and Hemoglobin for females and Packed cell volume for 
males were insignificantly changed while values of Hb for males and PCV for females 
were significantly changed in group 3 in comparison with healthy controls (34) 
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PRIMARY OBJECTIVE: 
To study the inflammatory markers in new sputum positive tuberculosis and its 
response to anti tubercular treatment. 
SECONDARY OBJECTIVE:  
To assess the correlation of mean levels of  inflammatory markers with the disease 
severity. 
AIM:  
To prove that inflammatory marker levels reflects the disease severity and its 
decline reflects response to treatment, thus these inflammatory markers can be used as an 
adjunct in microbiologically confirmed TB cases and as a prime tool in clinically 
diagnosed cases . 
SAMPLE SIZE:  
The sample size was determined by using Open Epi software 2.1.3 Version with 
95% confidence interval and considering 10% attrition rate sample size of 115 + 11.5 ≈ 
127 samples will included in this study. 
The estimated sample size was 127. 
SUBJECT SELECTION: 
Patients attending the thoracic medicine outpatient clinic in government 
Thiruvotteswarar hospital of thoracic medicine (GTHTM) and government Kilpauk 
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Medical College (KMC), Government Royapettah Hospital (GRH), with newly detected 
sputum positive pulmonary tuberculosis. 
Symptoms of pulmonary tuberculosis suspect are fever, weight loss, significant 
weight loss, hemoptysis any abnormalities in chest radiograph as per technical 
operational guidelines 2016. 
 Such patients suspected of pulmonary tuberculosis screened with sputum smear 
examination for acid fast bacilli and new sputum positive patients of pulmonary 
tuberculosis who are not taken anti tuberculous treatment before are selected for study. 
INCLUSION CRITERIA : 
 Patients with new sputum positive pulmonary tuberculosis . 
 Age  >18  < 70 years 
EXCLUSION CRITERIA   : patients with following co-morbidties 
 Previous anti tubercular treatment 
 COPD 
 Bronchial Asthma 
 Ischemic heart disease 
 Decompensated liver disease 
 Diabetes mellitus 
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 Renal failure 
 Peripheral vascular disease 
 Patients with HIV 
 Patients with Collagen vascular disease&patients on chronic drugs 
STUDY CENTRES: 
The study was conducted at three tertiary care institutes  
Government Thiruvoteeswarar hospital of thoracic medicine, chennai 
Government Kilpauk Medical College, Chennai 
Government Royapettah Hospital, Chennai. 
STUDY DESIGN: 
The study was a prospective cross sectional study. 
No specific intervention was carried out. 
No controls have been used in study. 
SAMPLING: 
Simple random sampling 
DURATION OF STUDY: 6 months 
CONFLICT OF INTEREST: nil 
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HAZARDS OF STUDY: nil 
DATA COLLECTION: 
The data of each patient was collected on a proforma 
Sl No: Date: 
Name: 
Age 
Gender: 
Address 
         Phone: 
BMI: Underweight (< 18.5)  Normal (18.5-24.9) 
Overweight (25.0-29.9)Obese (>=30 ) 
         Duration of symptoms:  
        Smoking history 
    
Treatment CPR ESR NLR RDW 
Before Rx     
At 2months     
Treatment Sputum AFB  
Before Rx  
At 2months  
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Presumptive pulmonary tuberculosis patients 
( Cough,  fever, hemoptysis ,abnormalities in            
chest xray, weight loss) 
Sputum AFB examination 
  Positive                 
 negative               
  1+   ,  2+,     3+ 
 Chest x ray  
excluded                
  ANTI TUBERCULOUS TEATMENT 
      2 months intensive phase 
BEFORE TREATMENT 
INFLAMATORY MARKERS 
       ESR, CRP, RDW, NLR. 
DOTS 
2 months 
Adherence monitoring 
AFTER 2 MONTHS 
SPUTUM AFB 
CHEST XRAY 
 INFLAMATORY MARKERS   
 (ESR, CRP, RDW, NLR) 
  MILD, MODERATE, SEVERE 
METHODOLOGY 
 `   
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INFLAMMATORY MARKERS 
C-REACTIVE PROTEIN 
 
 
 
C reactive protein is annular (ring shaped) pentameric protein found in blood plasma, 
whose levels rise in response to inflammation. It is an acute –phase protein of hepatic 
origin that increases following interlukin-6 secretion by macrophages and T cells. Its 
physiological role is to bind lyso-phospatidyl choline expressed on surface of dead or 
dying cells ( some types of bacteria) in order to activate the compliment system via c1q(7) 
In healthy adults, the normal concentration of CRP varies between 0.8 mg/l to 3.0 
mg/l. However, some healthy adults show elevated CRP at 10 mg/l. When there is a 
stimulus, the CRP level can rise 10,000 fold from less than 50 micro gram /Litre to more 
than 500 mg/l. Such levels can rise to 5mg/l by 6 hours and peaks at 48 hours. The 
plasma half life of CRP is 19 hrs. Such half-life is constant in all medical conditions. The 
rate of CRP production increases with inflammation infection, trauma, necrosis, 
malignancy and allergic reaction.(8) 
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Acute phase response occurs as a result of a rise in the concentration of IL-
6,which is produced by macrophages as well as adipocytesin response to a wide range of 
chronic inflammatory conditions such a bacterial, viral or fungal infections. IL-6 
stimulates the liver to produce CRP. 
CRP is used as a marker of inflammation apart from liver failure, there are few 
known factors that interfere with CRP production. Interferon alpha inhibits CRP 
production from liver cells which may explain the relatively low levels of CRP found 
during viral infections compared to bacterial infections.(7) 
Measuring and charting CRP values can prove useful in determining disease 
progress or the effectiveness of treatments. ELISA, immune turbidometry, nephelometry, 
rapid immunodiffusion and visual agglutination are all methods used to measure CRP. 
Normal levels increase with aging. Higher levels are found in late pregnant 
women, mild inflammation and viral infections 10-40 mg/L). Active inflammation and 
bacterial infection ( 40 – 200mg /L),severe bacterial infections and burns (>200mg/L). 
CRP is a better reflector of the acute phase response than the ESR (erythrocyte 
sedimentation rate ) ESR may be normal while CRP is elevated. CRP returns to normal 
more quickly than ESR in response to therapy.(7)  CRP correlates with the erythrocyte 
sedimentation rate (ESR) ,however not always directly. This is due to the ESR being 
largely dependent on elevation of fibrinogen, an acute phase reactant with half life of 
approximately one week. This protein will therefore remain higher for longer despite 
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removal of inflammatory stimuli. In contrast CRP (with a half life of 6-8hrs) rises rapidly 
and can quickly return to within the normal range if treatment is employed. In our study 
we did CRP for our patients as an inflammatory marker of active pulmonary tuberculosis. 
The method used is blood CRP by immune turbidometry. Laboratory reference range is 
less than 5.0 mg /L  
ERYTHROCYTE SEDIMENTATION RATE 
 
The erythrocyte sedimentation rate is the rate at which red blood cells sediment in 
a period of one hour.it is a common hematology test, and is a nonspecific measure of 
inflammation.To perform the test, anti -coagulated blood was traditionally placed in an 
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upright tube, known as westergren tube, and rate at which red blood cells fall was 
measured and reported in mm at the end of one hour. 
There are 3 stages in erythrocyte sedimentation 
1) Stage 1: Rouleaux formation 
2) Stage 2: Sedimentation or settling stage 
3) Stage 3: Packing stage - 10 minutes (sedimentation slows and cells start to pack at the 
bottom of the tube) 
In normal conditions, the red blood cells are negatively charged. Therefore, 
negatively charged red blood cells repel each other and do not stack over each other. 
Besides, if the viscosity of blood is high, red blood cells would be slow to fall to the base, 
thus lowering the ESR. The rate of erythrocyte sedimentation is affected by 
both inflammatory and non-inflammatory conditions. 
The ESR is governed by balance between pro sedimentation rates, mainly 
fibrinogen, and those factors resisting sedimentation, namely the negative charge of the 
erythrocytes (zeta potential). When an inflammatory process is present, the high 
proportion of fibrinogen in the blood causes red blood cells to stick to each other. The red 
cells form stacks called rouleaux, which settle faster, due to their increased density. ESR 
begins to rise at 24 to 48 hours of inflammation, decreases slowly as inflammation 
resolves, and can take weeks to months to return to normal levels Creactive protein (CRP). 
Therefore, it is a better marker for acute phase reaction than ESR. While ESR and CRP 
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generally together correlate with the degree of inflammation, this is not always the case 
and results may be discordantin 12.5% of the case.The normal range of ESR adults 
westergrens method men <15 mm /hr, women <20 mm/hr. we did ESR by westergren’s 
method in our study. 
RED CELL DISTRIBUTION WIDTH 
 
 The width in RDW-CV is sometimes thought to be misleading, because it in fact is 
a measure of deviation of the volume of RBCs, and not directly the diameter. However, 
"width" refersto the width of the volume curve (distribution width, here presented as the 
Coefficient of Variation, or CV), not the width of the cells. Thus, it is a reasonably 
accurate term. RDW is a parameter that measures variation in red blood cell size or red 
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blood cell volume. RDW is elevated in accordance with variation in red cell size - 
anisocytosis  that is when elevated RDW is reported on complete blood count ,marked 
anisocytosis ( increased  variation in red cell size ) is expected on peripheral blood smear 
review. 
The reference range of RDW is as follows: 
RDW-SD 39-46 Fl 
RDW- CV 11.6-14.6 % in adults. 
Reference ranges may vary depending on the individual laboratory and also patient’s age. 
Mathematically, the RDW-CV is calculated with the following formula: 
RDW-CV = (Standard deviation of MCV ÷ MCV) × 100. 
Depending on the types of hematology analyzer instruments , RDW can be reported 
statistically as coefficient of variation (CV) and or standard deviation (SD),RDW-CV and 
or RDW –SD, respectively. RDW –SD (express in fl) is an actual measurement of width 
of the RBC size distribution histogram as is measured by calculating the width (in fl )at 
the 20% height level of the RBC size distribution histogram. This parameter is therefore 
not influenzed by average RBC size.( mean corpuscular volume - MCV) 
RDW-CV (express in %) is calculated from standard deviation and MCV as follows 
RDW-CV% = 1 standard deviation of RBC volume/MCV * 100%. 
Of note since RDW-CV is mathematically derived from MCV, it is there ore affected by 
the average RBC size (MCV). RDW is useful in determining various types of anemias. 
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RDW is a recently described novel biomarker that has shown to be predictive of 
outcomes in pulmonary tuberculosis. although plausible patho-biological mechanisms 
explaining the relationship of RDW are yet to be elucidated, both inflammation and 
oxidative stress believed to play a role the molecular basis of the above mentioned 
association has been mainly attributed to the ability f the RDWs capability to reliably 
reflect an increase in the levels of circulatory cytokines, such as interlukin-6, tumor 
necrosis factor alpha and hepcidin. Thus the RDW which is available in the complete 
blood count serve as inflammatory marker in PTB. In last years the interest in this marker 
has considerably grown and now a lot of data are available indicating that this simple and 
inexpensive parameter is a strong and independent risk factor for severity and prognostic 
indicator in pulmonary tuberculosis. Moreover, several investigations have been 
performed to investigate the role of RDW in inflammatory and infectious disorders. 
Generalized, it seems plausible to affirm that RDW can be useful by adding prognostic 
information in patients with tuberculosis. In our study we collected patient’s whole blood 
by vene puncture in an EDTA tube containing EDTA potassium salt additive as an 
anticoagulant and analysed in auto analyzer. Thus RDW is analysed as a part of CBC.In 
our study we have taken red cell distribution width by CV that is RDW-CV as a marker 
of inflammation. 
NEUTROPHIL LYMPHOCYTE RATIO: 
Neutrophil lymphocyte ratio is a simple parameter to assess easily the 
inflammatory status of the subject. It has proven its usefulness in the stratification as a 
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marker of inflammatory or infectious pathologies. Recently many studies have suggested 
that neutrophil to lymphocyte ratio may be potential bio marker for PTB severity. Many 
studies have found a higher NLR in advanced PTB compared to mild to moderate PTB. 
Neutrophil lymphocyte ratio alert us to the fact that the immune system is dysregulated 
from inflammation and the patient at high risk of mortality. 
Using results from a complete blood count with differential, it is easy to calculate 
the ratio of absolute neutrophil count to lymphocyte counts. If the neutrophil counts are 4 
times greater than lymphocytes (>4:1) then the patient has poorer prognosis than if the 
ratio were less than 4:1.  The normal NLR levels in a healthy adult range between 0.78 
and 3.53. 
In our study we analysed anticoagulated blood samples of patients in auto 
analyser. The absolute neutrophil count divided by lymphocyte ratio to calculate NLR. 
SPUTUM AFB SMEAR: 
In pulmonary tuberculosis, sputum is the specimen of choice. The sputum 
specimen is collected in a sterile container. It is a common misassumption that 
mycobacterial specimens are decontaminated before inoculation for culture. Thus the 
cleanliness of the sputum container is not important. Unsterilized containers may be 
contaminated with environmental mycobacteria.  To facilitate the choice of container, 
following specifications  are recommended for a container: 1) wide mouthed so that the 
patient can expectorate easily inside the container without contaminating it from outside; 
2) volume capacity of approximately 25 ml; 3) made of transparent material in order to 
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observe specimen volume and quality without opening the container; 4) screw-capped to 
obtain a water-tight seal, to reduce the risk of leakage during transport; 5)easily-
labelledto allow permanent identification; and 6) rigid, to avoid breakage during transit. 
An ideal container is the 28 ml universal container, which is a heavy glass, screw-
capped bottle. This container is reusable after thorough cleaning and sterilization. The 
identification number can be permanently on the bottle cap. In TB diagnosis, care must 
be taken to obtain adequate and satisfactory specimens. Correct collection and 
transportation of specimens to the laboratory are important to ensure that the results are 
accurate and reliable. 
 Grades according to the number of bacilli per high power field seen with 
fluorescent staining. 
No. of bacilli per high power field Grade 
Less than 6 per field 1+ 
6 to 100 bacilli per field 2+ 
More than 100 per field or large clumps 3+ 
 
Grades according to the number of bacilli seenWith Ziehl-Neelsen staining 
No. of AFB Fields Report 
None per 100 oil immersion fields Negative 
1-9 per 100 oil immersion fields Scanty [exact number reported] 
10-99 per 100 oil immersion fields 1+ 
1-10 per oil immersion field 2+[50 fields examined] 
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     Use of microscopy in diagnosis of TB is of paramount importance, as culture 
takes a long time before the results are ready. Microscopy is also helpful in the detection 
of open or infectious cases. Stained smears are examined directly from the sputum and 
after concentration.The tubercle bacilli are Gram positive though they do not take the 
stain readily. Mycobacteria retain the primary stain even after decolourization with acid 
alcohol;hence the term “acid-fast”. A counter-stain is employed to highlight the stained 
organisms for easierrecognition. There are several methods of   acid-fast nature of 
mycobacteria. In the carbol-fuchsin [Ziehl-Neelsen] procedure, acid-fast organisms 
appear red against a blue background. Acid fastness is based on the integrity of cell wall. 
Beaded or barred forms are frequently seen in Mycobacterium tuberculosis while 
Mycobacterium bovis stains more uniformly. In younger cultures, non -acid-fast rods and 
granules have been reported. The mycobacterial cell wall is complex in nature. It has high 
lipid content, which accounts for about 60 per cent of the cell wall weight. The cell wall 
has several distinct layers. The inner layer, overlying the cell membrane is composed of 
peptidoglycan [murein]. External to the murein is a layer of arabinogalactan which is 
covalently linked to a group of long chain fatty acids termed mycolic acid. These form a 
dense pallisade, arranged in rope-like structure, which gives the cell wall its thickness 
and is largely responsible for acid fastness. Acids termed mycolic acid. These form a 
dense pallisade, arranged in rope-like structure, which gives the cell wall its thickness 
and is largely responsible for acid fastness. It has been shown that at least 10 000 bacilli 
per ml of sputum are required for direct microscopy to be positive. The sensitivity can be 
further improved by examining more than one specimen from a patient. Examination of 
54 
 
two specimens will, on an average, detect more than 90per cent of cases and the addition 
of a third specimen increases the percentage to approximately 95 to 98 percent. A 
negative smear, however, does not exclude the diagnosis of TB as some patients harbor 
fewer numbers of bacilli which cannot be detected by direct microscopy. A poor quality 
specimen or smear may also produce negative results. New glass slides should be used 
for making smears as acid-fast bacilli [AFB] are not always removed from the old slides. 
Only those reagents and diluents should be used which have been shown to be free of 
environmental mycobacteria to avoid false positive smears. Direct examination is 
performed by selecting a purulent looking portion of sputum and spreading it thinly on a 
glass slide with a bacteriological loop or a wooden stick. The watery part of sputum is 
less likely to contain bacilli. The AFB are seen as bright red rods against the blue, green 
or yellow background [depending upon the counterstain used in staining]. A negative 
result does not exclude TB. As recommended by World Health Organization [WHO], 
before declaring a slide negative it is essential that at least 100 fields are examined taking 
over at least 10 minutes. Smears can be graded according to the number of bacilli seen, 
which was described in previous page. 
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ROENTGENOGRAPHY IN PULMONARY TB: 
PRIMARY PULMONARY TB: 
Parenchymal consolidation 
Tuberculoma 
Miliary tuberculosis 
Lymphadenopathy 
Airway involvement 
Pleural effusion 
POST PRIMARY TB: 
Local exudative / fibro productivelesion 
Tuberculoma, Cavitation 
Bronchogenic spread, Miliary tuberculosis 
Broncho stenosis, Pleural effusion 
Grading the disease severity by radiology plays paramount importance regarding 
the disease extent and progress,but there is no validated system so far grading the severity 
of chest x ray abnormalities in bacteriologically proven pulmonary tuberculosis. 
Problems in chest x ray reporting arise from the heterogenous chest xray manifestations 
of pulmonary tuberculosis and to inaccuracies inherent in chest xray performance and 
interpretation, including inter observer variation.Despite these short comings, the utility 
of CXR is well established in tuberculosis diagnosis and monitoring clinically. Many 
chest x ray scores available for use in adults which predicts the outcome which correlates 
with bacteriological and clinical severity markers. The scoring systems assess the extent 
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of involvement of lung fields, percentage of lung involvement,Presence of cavities, 
presence of pleural effusion etc. 
We have taken one such simple scoring system for grading the radiological 
severity. We divide the study patients into mild, moderate, severe disease according to it 
we have taken dlugovitzky et al.,criteria for classifying. 
MILD: single lobe involvement and no visible cavities or pleural involvement 
MODERATE: Unilateral involvement of two or more lobes with a solitary cavity 
or mild extent plus pleural involvement or effusion 
SEVERE: bilateral involvement and multiple cavities OrModerate extent plus 
pleural involvement or effusion. 
STATISTICAL ANALYSIS  
Statistical analysis was done using the Microsoft Excel and SPSS software with 
the help of a statistician. P value is used to assess the significance of correlation between 
variables. A statistically significant correlation is one in which  
Pearson correlation is used to assess the strength of correlation between variables  
Pearson correlation:  
> 0.5 - Strong correlation  
0.3 to 0.5 - Moderate correlation  
0.3 - Weak correlation  
Chi-square Test:  
 Chi-square test is performed between two groups and its statistical significance is 
calculated.  
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The chi-square (χ2) test of independence is used to test for a statistically significant 
relationship between two categorical variables. The term "degrees of freedom" is used to 
refer to the size of the contingency table on which the value of the Chi Square statistic 
has been computed 
P value is calculated using Excel CHITEST function:  
If P value ≤ 0.05 → statistically significant  
If P value > 0.05 → statistically in significant 
 
 
 
 
 
 
 
 
 
 
 
 
58 
 
 
 
 
 
 
 
 
RESULTS 
 
 
 
 
 
 
 
 
 
 
 
 
 
59 
 
DESCRIPTIVE STATISTICS 
 
GENDER DISTRIBUTION 
In our study males accounted for 74% and females accounted for25 %. 
 
 
Table 1: Gender wise distribution 
 
 
 
 
  
Fig: 1 
 
 
75, 74%
26, 26%
SEX
Male
Female
Sex Frequency percent 
Male 75 74.3 
Female 26 25.7 
Total 101 100 
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AGE DISTRIBUTION: 
In our study the mean age distribution is 40 years with maximum 70 years and minimum 
age 18 years. 
 
Table: 2 Age distribution among study subjects 
Age  
Mean 40.44 
Median 43.00 
Standard Deviation 11.321 
Minimum 18 
Maximum 70 
 
 
 
 
Fig:2 
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SPUTUM CATEGORY OF PARTICIPANTS 
In our study mild disease with 1+ sputum predominated 38.6%followed by sputum 3+ 
about 33% and scanty and 2+ and scanty accounted for 14% each. 
Table 3: Sputum Category of study participants 
 
 
 
 
 
 
 
 
 
 
 
 
  
0
5
10
15
20
25
30
35
40
1+ 2+ 3+ scanty
Sputum category 
Series 1
Sputum 
category 
Frequency Percent 
1 + 39 38.6 
2 + 14 13.9 
3 + 34 33.7 
Scanty 14 13.9 
total 101 100 
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DISTRIBUTION OF DISEASE SEVERITY BY SPUTUM ACCORDING TO 
GENDER 
Table 4: Distribution of disease severity by sputum according to gender 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig: 4 
 
 The males were more in number in mild disease and severe disease.males and females 
are equal in number in moderate diseasein severe disease that is with 3+ sputum there 
were no females. 
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1+ & scanty 2+ 3+
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Female
 
Sputum 
category 
SEX Total 
Male Female 
1+ 34 19 53 
2+ 7 7 14 
3+ 
34 
 
0 34 
Total 
 
75 
 
26 101 
 
 
Pearson 
Chi-
Square 
 
Value 
 
df 
 
Asymp. Sig. (2-
sided) 
18.928a 2 .000 
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Distribution of Severity According To Radiology 
 
Table: 5 Distribution of Severity According To Radiology 
 
 
 
 
 
 
In our study the person with mild, moderate, severe disease according to 
radiological grading are 30%, 27%, and 44% respectively 
 
 
0
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40
45
50
mild moderate severe
Disease severity by Radiology
Category Frequency percent 
mild 30 29.7 
moderate 27 26.7 
severe 44 43.6 
total 101 100 
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Distribution of disease Severity by Radiology according To Gender 
 
Table: 6 Distribution of Severity by Radiology According To Gender 
 
 
 
 
 
 
 
 
 
 
Fig:6 
 
 
 
 
 
 
 
In our study in mild disease both male and females are almost equal n=16 and n=14 
respectively. In moderate disease males predominated n=18 when compared to females 
n=9.in severe disease males were dominant n=41,but only few females n=3 
 
Severity 
SEX Total 
Male Female 
1 16 14 30 
2 18 9 27 
3 
 
41 
3 44 
Total 75 26 
 
101 
 
 
 
Pearson 
Chi-
Square 
 
Value 
 
df 
 
P value 
15.928a 2 .000 
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14
9
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Mild Moderate Severe
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Female
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C-REACTIVE PROTEIN 
 
 
Table: 7 C-REACTIVE PROTEIN 
 
 
 
 
Fig:7 
 
 
 
In this study the mean CRP in males before treatment was 58.4 and it decreased after 
treatment to 25.5 .whereas in females mean CRP was 28.6 before and 7.8 after treatment 
.so the mean CRP is in Slightly higher range in men both before and after treatment. 
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male female
Mean crp according to gender
before rx after rx
Parameter Sex Before rx After rx 
CRP Male 58.4+/-29.8 23.5+/- 15.3 
 female 28.6+/- 23.4 7.8 +/- 10.2 
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ERYTHROCYTE SEDIMENTATION RATE 
 
Table: 8 ERYTHROCYTE SEDIMENTATION RATE 
 
 
 
 
 
 
 
Fig:8 
 
 
The mean ESR in men is 54.6 mm/hrbefore treatment and that of after treatment is 
31.6mm/hr.in females it is 41.8mm/hr and 26.8mm/hr before and after treatment 
respectively 
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male female
Mean ESR according to gender
before rx after rx
parameter sex Before 
treatment 
After 
treatment 
ESR Male 54.6+/ 24.5 31.6 +/- 7.39 
 female 41.8 +/- 
10.7 
26.85 +/- 5.17 
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NEUTROPHIL LYMPHOCYTE RATIO 
 
 
Table: 9 NEUTROPHIL LYMPHOCYTE RATIO 
 
 
 
 
 
 
Fig :9 
 
 
The mean NLR IN male is 6.06 and 3.79 before and after treatment respectively,and that 
of female is 4.19 and 3.23 before and after treatment respectively 
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male female
Mean NLR according to gender
before rx after rx
Parameter Sex Before rx 
 
After rx 
NLR Male 6.06+/- 2.3 
 
3.79 +/- 1.2 
 Female 4.19 +/- 
1.27 
3.23 +/- 
0.56 
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RED CELL DISTRIBUTION WIDTH 
 
Table: 10 RED CELL DISTRIBUTION WIDTH 
 
 
 
 
 
 
Fig:10 
 
 
 
The mean RDW in men are 14.8 and 13.8 before and after treatment respectively, as 
that of women were 15.3 and 1.5 before and after treatment respectively. 
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Mean RDW according to gender
before rx after rx
Parameter Sex Before rx After rx 
RDW Male 
 
14.8+/-1.5 13.8 +/- .98 
 female 15.3 +/- 1.7 13.5 +/- 0.72 
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INFLAMMATORY MARKERS ACCORDING TO SEVERITY 
(RADIOLOGICAL) 
Fig:11Inflammatory markers according to severity (radiological) 
C-reactive protein 
 
Fig:12 Erythrocyte sedimentation rate 
 
 
 
 
 
 
 
 
 
When comparing the mean value of CRP and ESR,their levels are highest,higher and high 
in severe, moderate, mild disease respectively.Thus their mean levels closely reflects the 
severity. (radiology) 
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Fig: 13Neutrophil lymphocyte ratio
 
Fig:14 Red cell distribution width 
 
 
 
The mean values of the neutrophil lymphocyte ratio and red cell distribution width are 
highest, higher,high in mild, moderate, severe disease respectively thereby reflecting the 
severity  
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RESPONSES OF INFLAMMATORY MARKERS DURINGTREATMENT 
Table: 11 RESPONSES OF INFLAMMATORY MARKERS DURING 
TREATMENT 
 
 
 
 
 
 
 
Fig: 14   
 
 
The mean values of CRP fall significantly after treatment for 2months in both males 
and females. 
 
0 Months 2 Months
Male 58.7 28.6
Female 28.6 7.8
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M
E
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N
C
R
P
Male
Female
CRP Before 
treatment 
After 
treatment 
P value 
MALE 58.4 +/- 29.8 23.5 +/-15.3 0.001 
FEMALE 28.6 +/- 23.4 7.8 +/- 10.2  
72 
 
Table: 12 Erythrocyte sedimentation rate 
 
 
 
 
 
 
* Paired T test 
Fig: 15  
 
 
 
The mean values of ESR fall significantly after treatment for 2months in both males 
and females. 
 
 
O Months 2 Months
Male 54.6 31.6
Female 41.8 26.8
0
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M
E
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N
E
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R
Male
Female
ESR Before treatment After treatment P value 
MALE 54.6 +/- 24.5 31.6+/ 7.39 0.001 
FEMALE 41.8      ±  10.07 26.85  ±    5.17  
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Table: 13 Neutrophil lymphocyte ratio 
 
 
 
 
 
Fig: 16 
 
 
 
 
The mean values of NLR fall significantly after treatment for 2months in both males and 
females. 
 
 
O Months 2 Months
Male 6.1 3.8
Female 4.19 3.23
0
1
2
3
4
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7
M
E
A
N
N
L
R
Male
Female
NLR Before treatment After treatment P value 
MALE 6.06  +/-  2.3 3.79 +/- 1.2 0.004 
FEMALE 4.19     ±  1.27 3.23  ±    0.56 0.001 
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Table: 14 Red cell distribution width 
 
 
 
 
 
Fig: 17 
 
 
 
 
The mean values of RDW fall significantly after treatment for 2months in both males and 
females. 
 
O Months 2 Months
Male 14.8 13.8
Female 15.3 4.4
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W
Male
Female
RDW Before treatment After treatment P value 
MALE 14.8 +/-  1.5 13.8  +/- 0.98 0.004 
FEMALE 15.3   ±  1.7 13.5  ±    0.72 0.044 
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INFLAMMATORY MARKERS LEVELS ACCORDING TO SPUTUM             
CATEGORY 
Fig: 18 
 
Fig: 19 
 
When comparing the mean value of CRP and ESR, their levels are highest,higher and 
high in severe, moderate, mild disease respectively.Thus their mean levels closely 
reflects the severity.(by sputum category) 
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Fig: 20 
 
 
Fig: 21 
 
 
 
When comparing the mean value of CRP and ESR, their levels are highest,higher and 
high in severe, moderate, mild disease respectively.Thus their mean levels closely 
reflects the severity (by sputum category) 
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Table: 15 Hematological parameters that demonstrated significant difference based 
on the sex and severity of TB patients before initiation of anti-TB drugs compared 
with after completion of the intensive phase of treatment 
Parameter  Sex  Before Rx After Rx P Value  
CRP Male  (75) 58.4 ± 29.8 23.5 ± 15.3 0.001* 
Female  (26) 28.6 ± 23.4 7.8  ± 10.2  
Severity     
Mild    (30) 21.04±12.8 4.7 ± 4.8 0.047* 
Moderate  (27) 43.3±11.0 18.1  ± 10.7 0.013* 
Severe   (44) 75.61±28 30.6  ± 14.5 0.001* 
 
 
 
ESR 
Sex     
Male  54.6±24.5 31.6   ± 7.39  
Female  41.8 ±  10.07 26.85  ± 5.17 0.756 
Severity     
Mild  37.1     ±  8.04 27.63   ±    5.96 0.66 
Moderate  41.6   ±   8.2 27  ±    3.5 0.04* 
Severe  67.0±      25.2 34.3  ±   7.7 0.001* 
 
 
 
 
Sex     
Male  6.06  ±    2.3 3.79  ±     1.2  
Female  4.19   ±   1.27 3.23   ±    0.56 0.004* 
Severity     
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NLR Mild  3.8  ±  0.59 3.16  ±    0.48 0.006* 
Moderate  4.6   ±  1.2 3.5   ±  0.64 0.535 
Severe  7.39  ±  2.2 4.07  ±   1.51 0.105 
 
 
   RDW 
Sex     
Male  14.8   ±  1.5 13.8    ±    0.98  
Female  15.3 ±  1.7 13.5    ±     0.72 0.044* 
Severity     
Mild  14.4  ±  1.3 13.2  ±  0.52 0.15 
Moderate  14.8   ±   1.5 13.8  ±    0.83 0.05* 
Severe  15.3   ±   1.6 14.04  ±   1.06 0.04 * 
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Parameter   Before Rx After Rx P Value   
CRP 1 + 33.32    20.8 11.06    
11.91 
0.001  
2 + 57.9   30.4  21.2    15.3 0.001  
3 + 75.0     27.7 32     12 0.001  
ESR 1 + 42.6    17.4   28.4    5.42 0.001  
2 + 52.2    14.3  30.3    6.04 0.032  
3 + 64.5    25.8 33.4    8.8 0.001  
     
 
 
NLR 
1 + 4.5    1.4   3.3    0.69 0.001  
2 + 6.09    2.4 3.7       0.70 0.001  
3 + 6.9   2.66 4   1.66 0.186  
      
 
 
   RDW 
1 + 14.9    1.68 13.5   0.76 0.001  
2 + 15     1.81  14.3   1.77 0.268  
3 + 14.8    1.3 13.8    0.53 0.03  
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DISCUSSION 
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Our study sample is 127 of which only 101 patients finally included in the study.Two of 
the people turned out to be a multi drug resistant tuberculosis,15 people did  not come for 
follow up, 13 patients defaulted treatment, and 2 patients changed to alternative 
treatment. 
GENDER DISTRIBUTION: 
In our study population male patients accounted for about 75% and female patients 
accounted for about 25%.thus males predominated in the study.This probably shows men 
seek medical care more than women. 
AGE DISTRIBUTION: 
 The mean age of the patients is 40 years, with standard deviation of 11. The maximum 
age of the patient was 70 years, minimum age was 18 years. This reflects that TB 
predominantly affects the productive age group which is a major socioeconomic burden 
for the country. 
DISTRIBUTION OF DISEASE SEVERITY ACCORDING TO SPUTUM 
CATEGORY 
According to sputum category the patients were classified into mild, moderate and severe 
disease with 1+, 2+, 3+ sputum respectively. In this study 53% of the patients hadmild  
14 % patients had moderate category and 34% in severe category. Thus mild disease 
predominated which reflects the integrity of health system and awareness among people. 
According to gender mild and severe diseases males predominated and in moderate 
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disease it is in equal distribution.no female patients classified as severe disease which is 
may probably due to relatively less female study population. 
DISTRIBUTION OF DISEASE SEVERITY ACCORDING TO RADIOLOGY 
According to radiology 30 % patients are classified into mild disease, 27% into moderate 
disease,44% into severe disease thus there is discrepancy in classifying the severity 
between sputum category and radiology. The radiological evaluation detected more 
number of Moderate disease as compared to sputum grading. 
According to gender male and female distribution in mild disease it is almost equal, 
moderate and severe disease males predominated. Thus males suffer a relatively severe 
disease. 
INFLAMMATORY MARKERS AND DISEASE SEVERITY 
We have compared the inflammatory markers levels with disease severity by sputum 
category and radiological involvement.  
The mean CRP levels in mild disease as by radiology and sputum category are 21 mg /l 
and 33.3 mg/l respectively. The mean ESR level in mild PTB as by radiology and sputum 
category are 37.1 mm/ hr and 42.6 mm/hr respectively. The mean NLR in mild disease by 
radiology and sputum are 3.8 and4.5 respectively. The mean RDW in mild disease by 
radiology and sputum are 14.4 and 14.9 respectively. Thus the inflammatory markers are 
elevated more in sputum category than in radiological severity as far as mild disease is 
concerned. 
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The mean CRP levels in moderate disease as by radiology and sputum category are 43.3 
mg% and 57.9 mg % and  respectively. The mean ESR level in moderate PTB as 
byradiology and sputum category are 41.6mm/hr and 52.2 mm/hr respectively. The mean 
NLR in moderate disease by radiology and sputum are 4.6 and 6.09 respectively. The 
mean RDW in moderate disease by radiology and sputum are 14.8 and 15 respectively. 
Thus the inflammatory markers in moderate tuberculosis also are elevated more in 
sputum category than in radiological severity except for RDW which elevated more in 
moderate disease as determined by radiology.  
The mean CRP levels in severe disease as by radiology and sputum category are 
75.6mg% and 75.0mg % and  respectively. The mean ESR level in severe PTB as by 
radiology and sputum category are 67.0mm/hr and 64.5 mm/hr respectively. The mean 
NLR in severe disease by radiology and sputum are 7.39 and 6.9 respectively. The mean 
RDW in severe disease by radiology and sputum are 15.3 and 14.8 respectively. Thus the 
inflammatory markers in severe tuberculosis also are elevated more in sputum category 
than in radiological severity except for RDW which elevated more in severe disease as 
determined by radiology 
INFLAMMATORY MARKERS RESPONSE TO ATT 
The levels of CRP which is elevated during active disease decrease significantly after 2 
months of ATT in mild, moderate and severe disease with p value < 0.001. which is in 
accordance with many previous studies…done by abakay et al. furuhashi et al, mohd 
yousoof et al..etc 
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The ESR which is elevated in active disease fall significantly in moderate and severe 
disease (p value < .001) whereas its fall in mild disease is not statistically significant.( p 
value  0.66).this is in accordance with studies done by furuhashi et al, mahalakhmamma 
et al. but in all the reviewed studies all the patients they found statistically significant fall 
in ESR 
The NLR ratio elevated in active disease and fall significantly in mild disease ( p < 0.006 
) whereas in moderate and severe disease fall in its level not significant .( p=0.5).This is 
in accordance with various literatures examples…studies done by abakay et al, yin y et 
al,intheir studied they concluded high NLR in severe disease and retreatment cases. 
The red cell distribution width(RDW )levels which are elevated in active disease fall in 
response to active treatment but it is not statistically significant.This is in accordance with 
studies done by various authors bamalkku et al..,marina oliveria et al, their studies also 
did not show statistically significant decrease in RDW after treatment. 
Thus we find that CRP is a better marker indicating disease severity and prognosis 
followed by ESR. The RDW and NLR though were good markers of disease severity 
they are unreliable in assessing the disease prognosis and needs further study to prove its 
usefulness. 
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CONCLUSION 
 
 
 
 
86 
 
 Inflammatory markers levels are comparable to degree of severity both by 
radiological and microbiological criteria. P value < 0.001 
 The level of CRP correlates with disease activity. 
 Elevated ESR correlates significantly with disease activity only in moderate and 
severe disease. 
 NLR ratio correlates significantly only with mild disease 
 These findings can be extrapolated and may be useful in assessing the disease 
severity and follow up in pediatric TB and extra pulmonary TB where sampling 
from primary site are not always possible or correlation with other modalities of 
investigation are questionable. 
 Thus the development of non-sputum-based biomarkers of treatment response 
would represent an advance for individual monitoring of TB patients. 
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   PROFORMA 
DATA COLLECTION : 
The data of each patient was collected on a proforma 
Sl No: Date: 
Name: 
Age 
Gender: 
Address 
Phone: 
BMI   :Underweight (< 18.5)  Normal (18.5-24.9) 
Overweight (25.0-29.9)Obese (>=30 ) 
         Duration of symptoms:  
        Smoking history 
 
Treatment CPR ESR NLR RDW 
Before Rx     
At 2months     
Treatment Sputum 
AFB  
Before Rx  
At 2months  
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ABBREVIATIONS 
CRP- Creactive protein 
NLR-Neutrophil lymphocyte ratio 
RDW-Red cell distribution width 
ESR-Erythrocyte sedimentation rate 
PTB-Pulmonary tuberculosis 
ATT – Anti tuberculosis treatment 
SAA – Serum amyloid A 
APR – Acute Phase Reactants 
MDR-TB – Multi Drug Resistant Tuberculosis 
HIV – Human imunodefeciency Virus 
TLR – Toll Like Receptor 
IFN – Interferon 
IL - Interleukin 
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